Evidence map›Paper›PMID 39771364›Full record

ArticlePolymers2024

Antifungal Activity of Newly Formed Polymethylmethacrylate (PMMA) Modification by Zinc Oxide and Zinc Oxide-Silver Hybrid Nanoparticles.

Marek Witold Mazur, Anna Grudniak, Urszula Szałaj, Marcin Szerszeń, Jan Mizeracki, Mariusz Cierech, Elżbieta Mierzwińska-Nastalska, Jolanta Kostrzewa-Janicka

Abstract read
In one paragraph

Article in Polymers, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Marek Witold MazurDepartment of Prosthodontics, Medical University of Warsaw, 02-097 Warsaw, Poland.ORCID 0000-0003-4915-5743
Anna GrudniakDepartment of Bacterial Genetics, Institute of Microbiology, Faculty of Biology, University of Warsaw, 02-096 Warsaw, Poland.ORCID 0000-0002-3394-2913
Urszula Szałaj3 Laboratory of Nanostructures, Institute of High Pressure Physics, Polish Academy of Sciences, 01-142 Warsaw, Poland.ORCID 0000-0003-2304-1481
Marcin SzerszeńDepartment of Prosthodontics, Medical University of Warsaw, 02-097 Warsaw, Poland.ORCID 0000-0002-0887-5528
Jan Mizeracki3 Laboratory of Nanostructures, Institute of High Pressure Physics, Polish Academy of Sciences, 01-142 Warsaw, Poland.
Mariusz CierechDepartment of Prosthodontics, Medical University of Warsaw, 02-097 Warsaw, Poland.
Elżbieta Mierzwińska-NastalskaDepartment of Prosthodontics, Medical University of Warsaw, 02-097 Warsaw, Poland.
Jolanta Kostrzewa-JanickaDepartment of Prosthodontics, Medical University of Warsaw, 02-097 Warsaw, Poland.ORCID 0000-0003-1554-293X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Incorporating nanoparticles into denture materials shows promise for the prevention of denture-associated fungal infections. This study investigates the antifungal properties of acrylic modified with microwave-sintered ZnO-Ag nanoparticles. ZnO-Ag nanoparticles (1% and 2.5% wt.) were synthesized via microwave solvothermal synthesis (MSS). Nanoparticles were characterized for phase purity, specific surface area (SSA), density, morphology, and elemental composition. ZnO and ZnO-Ag nanoparticles were added to acrylic material (PMMA) at concentrations of 1% and 2.5% and polymerized. Pure PMMA (control) and obtained PMMA-nanocomposites were cut into homogeneous 10 × 10 mm samples. Antifungal activity of nanoparticles and PMMA-nanocomposites against

Indexed as

antifungal activitybiofilm inhibitionpolymethylmethacrylate (PMMA)silver nanoparticles (Ag NPs)zinc oxide nanoparticles (ZnO NPs)

Identifiers

PMID39771364
PMCPMC11677632

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.